156 related articles for article (PubMed ID: 4700931)
1. The probenecid test in Parkinson's disease.
Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
[No Abstract] [Full Text] [Related]
2. [Biochemical and clinical correlations in Parkinson's disease].
Barbeau A
Rev Neurol (Paris); 1972 Aug; 127(2):253-64. PubMed ID: 4603361
[No Abstract] [Full Text] [Related]
3. Monoamine metabolism and depression in Parkinson patients.
Puite JK; Schut T; van Praag HM; Lakke JP
Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
[No Abstract] [Full Text] [Related]
4. Dopaminergic nervous transmission in Parkinson's disease.
Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
[No Abstract] [Full Text] [Related]
5. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
Lal S; De la Vega C; Garelis E; Sourkes TL
Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
[No Abstract] [Full Text] [Related]
6. Biochemical aids in the diagnosis of Parkinson's disease.
Chase TN; Eng N; Gordon EK
Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
[TBL] [Abstract][Full Text] [Related]
7. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
[No Abstract] [Full Text] [Related]
8. [Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects].
Korf J; van Praagen HM; Lakke JP
Ned Tijdschr Geneeskd; 1975 Sep; 119(36):1373-8. PubMed ID: 241026
[No Abstract] [Full Text] [Related]
9. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
[No Abstract] [Full Text] [Related]
10. Central monoamine metabolism in Parkinson's disease.
Chase TN; Ng LK
Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
[No Abstract] [Full Text] [Related]
11. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
[No Abstract] [Full Text] [Related]
12. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
Rinne UK; Sonninen V; Marttila R
Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
[TBL] [Abstract][Full Text] [Related]
13. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
14. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
Voto Bernales J; Cruz GA; Davila E
Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
[No Abstract] [Full Text] [Related]
15. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
Faull KF; Kraemer HC; Barchas JD; Berger PA
Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
Parkes JD; Marsden CD; Rees JE; Curzon G; Kantamaneni BD; Knill-Jones R; Akbar A; Das S; Kataria M
Q J Med; 1974 Jan; 43(169):49-61. PubMed ID: 4822972
[No Abstract] [Full Text] [Related]
17. Clinical studies of dopaminergic mechanisms.
Chase TN
Adv Biochem Psychopharmacol; 1974; 12(0):427-34. PubMed ID: 4421041
[No Abstract] [Full Text] [Related]
18. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
[No Abstract] [Full Text] [Related]
19. [Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid].
Guard O; Renaud B; Chazot G
Encephale; 1976; 2(4):293-303. PubMed ID: 1001240
[TBL] [Abstract][Full Text] [Related]
20. Fusaric acid in Parkinson's disease.
Chase TN
Neurology; 1974 Jul; 24(7):637-9. PubMed ID: 4858086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
